跳至主要内容
临床试验/JPRN-UMIN000030308
JPRN-UMIN000030308已完成未知

A prospective feasibility study of cord blood transplant using once daily intravenous busulfan and fludarabine plus melphalan as conditioning regimen - FluBuOnceDaily plus Mel for CBT

Osaka International Cancer Institute0 个研究点目标入组 0 人开始时间: 2017年12月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

Because the schedule of treatment in this study was approved by the government, we decided to stop this trial.

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) patients with organ dysfunction (lung, renal, liver, heart) (2) patients who are expected not to survive 100 days or longer (3) patients with another active cancer (4) pregnant or breast-feeding (5) patients with mental disorder (6) the physician consider inappropriate for this study

研究者

相似试验